HLF Logo

HLF Stock Forecast: Herbalife Ltd. Price Predictions for 2025

Home โ€บ Stocks โ€บ United States | NYSE | Consumer Defensive | Packaged Foods

$8.05

-0.02 (-0.25%)

HLF Stock Forecast 2025-2026

$8.05
Current Price
$815.80M
Market Cap
5 Ratings
Buy 1
Hold 3
Sell 1
Wall St Analyst Ratings

Distance to HLF Price Targets

+61.5%
To High Target of $13.00
-3.7%
To Median Target of $7.75
-13.0%
To Low Target of $7.00

HLF Price Momentum

-9.2%
1 Week Change
+43.2%
1 Month Change
-10.2%
1 Year Change
+20.3%
Year-to-Date Change
-37.1%
From 52W High of $12.79
+59.7%
From 52W Low of $5.04

๐Ÿค” Considering Herbalife (HLF)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Latest HLF Stock Price Targets & Analyst Predictions

Based on our analysis of 9 Wall Street analysts, HLF has a neutral consensus with a median price target of $7.75 (ranging from $7.00 to $13.00). The overall analyst rating is Buy (6.4/10). Currently trading at $8.05, the median forecast implies a -3.7% downside. This outlook is supported by 1 Buy, 3 Hold, and 1 Sell ratings.

The most optimistic forecast comes from Chasen Bender at Citigroup, projecting a 61.5% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

HLF Analyst Ratings

1
Buy
3
Hold
1
Sell

HLF Price Target Range

Low
$7.00
Average
$7.75
High
$13.00
Current: $8.05

Latest HLF Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for HLF.

Date Firm Analyst Rating Change Price Target
Feb 20, 2025 DA Davidson Linda Bolton Weiser Neutral Maintains $7.50
Nov 1, 2024 Mizuho John Baumgartner Neutral Maintains $9.00
Oct 31, 2024 DA Davidson Linda Bolton Weiser Neutral Maintains $7.50
Oct 31, 2024 B. Riley Securities Jeff Van Sinderen Buy Maintains $12.00
Oct 25, 2024 Citigroup Chasen Bender Buy Maintains $13.00
Aug 1, 2024 B. Riley Securities Jeff Van Sinderen Buy Maintains $17.00
Aug 1, 2024 DA Davidson Linda Bolton Weiser Neutral Maintains $13.00
Jun 7, 2024 Mizuho John Baumgartner Neutral Maintains $11.00
May 2, 2024 DA Davidson Linda Bolton Weiser Neutral Maintains $9.50
Mar 25, 2024 DA Davidson Linda Bolton Weiser Neutral Maintains $9.50
Mar 21, 2024 Mizuho John Baumgartner Neutral Maintains $10.00
Mar 21, 2024 B of A Securities Anna Lizzul Underperform Maintains $8.00
Feb 17, 2024 Mizuho Neutral Maintains $0.00
Feb 16, 2024 Mizuho John Baumgartner Neutral Maintains $12.00
Nov 29, 2023 Mizuho John Baumgartner Neutral Maintains $14.00
Sep 14, 2023 DA Davidson Linda Bolton Weiser Neutral Initiates $13.50
Aug 3, 2023 Mizuho Neutral Maintains $0.00
Jun 7, 2023 Mizuho John Baumgartner Neutral Initiates $13.00
Mar 1, 2023 Citigroup Chasen Bender Buy Maintains $28.00
Feb 3, 2023 B of A Securities Anna Lizzul Underperform Initiates $14.00

Herbalife Ltd. (HLF) Competitors

The following stocks are similar to Herbalife based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Herbalife Ltd. (HLF) Financial Data

Herbalife Ltd. has a market capitalization of $815.80M with a P/E ratio of 3.2x. The company generates $4.99B in trailing twelve-month revenue with a 5.1% profit margin.

Revenue growth is -0.6% quarter-over-quarter, while maintaining an operating margin of +9.2% and return on equity of -31.7%.

Valuation Metrics

Market Cap $815.80M
Enterprise Value $2.87B
P/E Ratio 3.2x
PEG Ratio 4.0x
Price/Sales 0.2x

Growth & Margins

Revenue Growth (YoY) -0.6%
Gross Margin +77.8%
Operating Margin +9.2%
Net Margin +5.1%
EPS Growth +1,644.1%

Financial Health

Cash/Price Ratio +51.0%
Current Ratio 0.9x
Debt/Equity -3.1x
ROE -31.7%
ROA +10.6%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Herbalife Ltd. logo

Herbalife Ltd. (HLF) Business Model

About Herbalife Ltd.

What They Do

Develops and sells nutritional supplements globally.

Business Model

Herbalife operates a direct-selling business model, where independent distributors market and sell the company's nutritional and personal care products. This model not only generates product sales but also allows distributors to earn income through commissions and bonuses based on their sales and network growth.

Additional Information

Founded in 1980, Herbalife's products are available in over 90 countries. The company focuses on research and development and offers solutions in weight management, sports nutrition, and personal care. Herbalife is a major player in the health and wellness industry, adapting to various regulatory environments while influencing global consumer health trends.

Company Information

Sector

Consumer Defensive

Industry

Packaged Foods

Employees

8,600

CEO

Mr. Michael O. Johnson

Country

United States

IPO Year

2004

Herbalife Ltd. (HLF) Latest News & Analysis

HLF stock latest news image
Quick Summary

Herbalife Ltd. (NYSE: HLF) announced a binding agreement to acquire Pro2col Health LLC and Pruvit Ventures, and a 51% stake in Link BioSciences, enhancing its health and wellness digital offerings.

Why It Matters

Herbalife's acquisition of health tech firms enhances its product offerings and market position, potentially driving revenue growth and attracting investors seeking innovation in wellness.

Source: Business Wire
Market Sentiment: Neutral
HLF stock latest news image
Quick Summary

Herbalife Ltd (HLF) and Potbelly (PBPB) have been compared to their sector's performance in 2023. Specific performance metrics were not provided in the excerpt.

Why It Matters

Performance comparisons signal the relative strength or weakness of these companies within their sectors, influencing investor sentiment and potential stock movements.

Source: Zacks Investment Research
Market Sentiment: Positive
HLF stock latest news image
Quick Summary

Herbalife Ltd (HLF) has received a Zacks Rank #1 (Strong Buy) upgrade, indicating improved earnings prospects, which may boost the stock price in the near term.

Why It Matters

Herbalife's upgrade to a Strong Buy indicates strong earnings potential, likely leading to increased investor confidence and a potential rise in the stock price.

Source: Zacks Investment Research
Market Sentiment: Positive
HLF stock latest news image
Quick Summary

Herbalife operates in 95 countries with 6 million distributors but faces declining sales, partially offset by price increases. The sustainability of this trend is uncertain.

Why It Matters

Declining sales and reliance on price increases raise concerns about Herbalife's long-term growth. The shift post-FTC settlement may limit its MLM model's effectiveness, affecting investor confidence.

Source: Seeking Alpha
Market Sentiment: Positive
HLF stock latest news image
Quick Summary

GRMN, LNVGY, and HLF have been rated as Zacks Rank #1 (Strong Buy) momentum stocks as of February 26, 2025.

Why It Matters

GRMN, LNVGY, and HLF being ranked as Strong Buy indicates strong momentum and potential for price appreciation, signaling favorable investment opportunities.

Source: Zacks Investment Research
Market Sentiment: Positive
HLF stock latest news image
Quick Summary

HLF, XHR, and PAX were rated as Zacks Rank #1 (Strong Buy) value stocks on February 26, 2025.

Why It Matters

HLF, XHR, and PAX being ranked as Strong Buy value stocks indicates potential for price appreciation, attracting interest from value-focused investors seeking growth opportunities.

Source: Zacks Investment Research
Market Sentiment: Positive

Frequently Asked Questions About HLF Stock

What is Herbalife Ltd.'s (HLF) stock forecast for 2025?

Based on our analysis of 9 Wall Street analysts, Herbalife Ltd. (HLF) has a median price target of $7.75. The highest price target is $13.00 and the lowest is $7.00.

Is HLF stock a good investment in 2025?

According to current analyst ratings, HLF has 1 Buy ratings, 3 Hold ratings, and 1 Sell ratings. The stock is currently trading at $8.05. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for HLF stock?

Wall Street analysts predict HLF stock could reach $7.75 in the next 12 months. This represents a -3.7% decrease from the current price of $8.05. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Herbalife Ltd.'s business model?

Herbalife operates a direct-selling business model, where independent distributors market and sell the company's nutritional and personal care products. This model not only generates product sales but also allows distributors to earn income through commissions and bonuses based on their sales and network growth.

What is the highest forecasted price for HLF Herbalife Ltd.?

The highest price target for HLF is $13.00 from Chasen Bender at Citigroup, which represents a 61.5% increase from the current price of $8.05.

What is the lowest forecasted price for HLF Herbalife Ltd.?

The lowest price target for HLF is $7.00 from at , which represents a -13.0% decrease from the current price of $8.05.

What is the overall HLF consensus from analysts for Herbalife Ltd.?

The overall analyst consensus for HLF is neutral. Out of 9 Wall Street analysts, 1 rate it as Buy, 3 as Hold, and 1 as Sell, with a median price target of $7.75.

How accurate are HLF stock price projections?

Stock price projections, including those for Herbalife Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: March 15, 2025 3:33 AM UTC